Lorenz Räber

Trials

Studies that name Lorenz Räber as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:31 UTC. Open this list on ClinicalTrials.gov

• N/A
  NCT07565805 · Bern Intracoronary Optical Coherence Tomography and Coronary Computed Tomography Angiography Registry

  Insel Gruppe AG, University Hospital Bern · recruiting · Coronary Artery Disease (CAD) · study chair
• Ph3
  NCT07276282 · Effects of Ziltivekimab on Coronary Atherosclerotic Burden in Patients With Acute Myocardial Infarction

  ECRI bv · recruiting · Coronary Artery Disease, Acute Myocardial Infarction (AMI), Coronary Atherosclerosis of Native Coronary Artery · principal investigator
• N/A
  NCT05976685 · Early Closure of Left Atrial Appendage for Patients With Atrial Fibrillation and Ischemic Stroke Despite Anticoagulation Therapy

  Insel Gruppe AG, University Hospital Bern · recruiting · Ischemic Stroke, Atrial Fibrillation · principal investigator
• N/A
  NCT05732701 · Algorithm-based Tailoring of Dual Antiplatelet Therapy to Improve Outcomes Following Percutaneous Coronary Interventions

  Insel Gruppe AG, University Hospital Bern · recruiting · Percutaneous Coronary Intervention, Platelet Aggregation Inhibitors, Coronary Artery Disease · study chair
• N/A
  NCT05326828 · Implantable Cardiac Monitor to Detect Atrial Fibrillation in Patients With MINOCA

  Insel Gruppe AG, University Hospital Bern · recruiting · MINOCA, Atrial Fibrillation · principal investigator
• N/A
  NCT04628078 · LAAC-registry: Clinical Outcome After Echocardiography-guided LAA-closure

  Insel Gruppe AG, University Hospital Bern · recruiting · Atrial Fibrillation, Cardiovascular Diseases, Thromboembolism · principal investigator
• N/A
  NCT03399851 · Comparison of Amplatzer Amulet and Watchman Device in Patients Undergoing Left Atrial Appendage Closure. (SWISS-APERO)

  Insel Gruppe AG, University Hospital Bern · unknown · Left Atrial Appendage Closure · study chair
• N/A
  NCT03180931 · Independent OCT Registry on Very Late Bioresorbable Scaffold Thrombosis

  Insel Gruppe AG, University Hospital Bern · completed · Coronary Thrombosis, Tomography, Optical Coherence, Drug-Eluting Stents · principal investigator
• N/A
  NCT02683356 · Optical Coherence Tomography to Improve Outcome for Coronary Revascularisation Using Bioresorbable Vascular Scaffolds

  Insel Gruppe AG, University Hospital Bern · terminated · Coronary Occlusion · study chair
• N/A
  NCT02678871 · Combined Transcatheter Aortic Valve Implantation and Percutaneous Closure of the Left Atrial Appendage

  Insel Gruppe AG, University Hospital Bern · terminated · Aortic Valve Disorder · principal investigator
• N/A
  NCT02176265 · Qvanteq Bioactive Coronary Stent System First in Man (FIM) Clinical Investigation

  Qvanteq AG · completed · Coronary Artery Disease · principal investigator
• Ph4
  NCT00962416 · Comparison of Biomatrix Versus Gazelle in ST-Elevation Myocardial Infarction (STEMI)

  Insel Gruppe AG, University Hospital Bern · completed · ST-elevation Myocardial Infarction · study director

Grants

NIH projects from RePORTER, fetched 2026-11-12 10:31 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.

No NIH project could be tied to this name by a shared trial or a matching institution.